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Results: Dose-volume-histogram data for the standard (solid) 
and escalated (dashed) arms for one patient is presented 
(Figure 1). Centres entering the NARLAL2 trial must 
successfully pass a workshop evaluation on delineation, PET 
determination, treatment planning, and IGRT strategy. 
Additionally, all participating centres should expect to enrol 
≥5 patients/year, use 4D-CT and PET, inverse treatment 
planning, daily online match on soft tissue, and have an 
adaptive treatment strategy. Planning and treatment of the 
initial two patients within each centre are thoroughly 
investigated by a small QA work group consisting of 2 clinical 
oncologists and 4 physicists. Furthermore, every six month 
each centre will be visited by an external oncologist in order 
to ensure that guidelines are still followed throughout the 
duration of the trial. 
 
 
Conclusion: The NARLAL2 trial started patient accrual in 
January 2015 based on this extensive QA work. 
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Purpose or Objective: The purpose of the study was to 
compare a lithium formate dosimetry system with a lithium 
fluoride TL dosimetry system as used in a solid phantom 
developed for remote end-to-end audits of advanced 
radiotherapy treatments, such as IMRT and VMAT. This type 
of inter-dosimeter comparison is of benefit for better 
understanding of advantages and limitations in the use of 
these dosimeters in remote audit programs for radiotherapy.  
 
Material and Methods: A phantom was designed by a 
multinational coordinated research group (Coordinated 
Research Project E24018) with the intention to be used for 
remote end-to-end audits of advanced radiotherapy 
treatment (IMRT and VMAT). The phantom is made of 
polystyrene and includes solid water volumes representing a 
target region (PTV) and an organ at risk (OAR) with two 
measurement points in each. For an audit, the phantom is to 
be loaded with either TLD or EPR dosimeters and sent to 
external clinics to be treated using their local procedure for 
IMRT or VMAT. Dimensions of the active volume of the 
dosimeters used were: 20 mm length and 3 mm diameter for 
TLD, 5 mm height and 4.5 mm diameter for the EPR 
dosimeter. In addition, gafchromic film is used in the audit 
but this is not a subject of the current study. Irradiations 
were performed using VMAT technique and the doses 
determined by the TLDs and EPR dosimeters were compared 
with the TPS calculated doses.  
Results: The absorbed dose determined by the EPR and TL 
dosimeters agreed within 2% with the TPS calculated doses in 
the PTV. In the OAR the discrepancy was larger; the dose 
determined by the EPR system was 3% lower compared to the 
TPS dose while the dose determined by the TLD was 5% 
higher than the TPS dose. The dose difference in the OAR was 
expected to be larger due to the steep dose gradients in this 
region over the dosimeter volume and the phantom 
positioning uncertainties involved.  
 
Conclusion: Both dosimetry systems agree with the TPS 
calculated doses within 2% in the PTV and 5% in the OAR. This 
study shows that both dosimetry systems give results 
acceptable for this application and can be used for remote 
dosimetry audits of IMRT or VMAT. The EPR dosimeters have 
higher resolution due to their smaller size. This is an 
advantage of the EPRs over the TLDs since it is possible to 
resolve dose gradients to a higher extent.  
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Purpose or Objective: Radiotherapy is one of the primary 
treatment options in cancer management. Radiotherapy is 
recognised as one of the safest areas of modern medicine; 
however, when errors occur, the consequences for the 
patient can be significant.  
The rapid development of new technology has significantly 
changed the way in which radiotherapy is planned and 
delivered. Quality and safety programs in radiotherapy have 
been recommended by international bodies, such ESTRO and 
AAPM.  
The purpose of this work is twofold: to report on the long-
term use of an event reporting and learning system in an RT 
department to record and classify events, and to compare a 
restricted access system to an open-access system 
 
Material and Methods: A voluntary web-based safety 
information database for RT was designed for reporting 
individual events in RT and was clinically implemented in 
2011. An event was defined as any occurrence that could 
have, or had, resulted in a deviation in the intended delivery 
of cancer care. The aim of the reporting systemm was to 
encourage process improvement in patient care and safety.  
During the RT process, when something goes wrong and 
results in event, it is initially recorded and reported within 
the RT Department. Initially only the management group 
registered events. From June 2012 all team at RT Department 
(radiation oncologist, radiation therapists, medical physicists, 
nurses, technicians, dosimetrists, medical secretary) can 
directly register events. All events were analyzed inside a 
management group who selected and proposed actions to be 
taken. 
 
Results: We analyzed events from 2011 to 2014 for 6108 
patients who have undergone radiation treatment at our 
hospital. Over this period of time 298 events were reported. 
After the event reporting system became open access (June 
2012), the registered number of events increased significally: 
from 22 in 2011 to 44 in 2012, 120 in 2013 and 112 in 2014. 
The spectrum of reported deviations extendent from minor 
workflow issues to errors in treatment delivery. 
The distribution of the professional who registered the event 
was: 
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 2011 2012 2013 2014 
Radiation Oncologist 59% 18% 6% 4% 
Medical Physicists 4.5% 7% 2% 2% 
Dosimetrists - 5% - 7% 
Radiation Therapists 32% 70% 91% 87% 
Nurses 4.5% - - - 
Medical Secretary - - - 1% 
Nº of Events 22 44 120 112 
 
Dose errors were detected in 29 patients. In 9 patients 
afected more than 1 session (5 patients in 2011, 3 patients in 
2012, 1 patient in 2013 and no patients in 2014).  
The number of corrective actions has increased because of 
the increasing number of registered events: 2 in 2011, 4 in 
2012, 7 in 2013 and 9 in 2014. 
 
Conclusion: Event reporting and learning systems in 
radiotherapy can provide valuable data for patient safety 
treatment. An open acces event reporting improved 
identification of areas which needed process and safety 
improvements. The major indication of the effectiveness is 
the reduction in dose errors. 
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Purpose or Objective: Reference dosimetry audit 
measurements in UK radiotherapy centres have been carried 
out over the last 20 years. This work examines the variation 
in local dosimetry calibration in a network of radiotherapy 
centres, draws conclusions on the implementation of an 
absorbed dose based protocol for MV photon beams and 
includes the measured effect of a change in the nationally 
recommended electron code of practice (CoP) from an air 
kerma based to an absorbed dose based protocol. 
 
Material and Methods: Data from reference dosimetry audits 
conducted in radiotherapy centres by the National 
Measurement Institute (NMI) for photon, electron and kV x-
rays have been collated, recording the NMI:Centre ratio for 
reference output measurements, beam quality, and field 
chamber comparison. A total of 81 MV photon, 98 electron 
and 30 kV photon beams were measured during 68 visits 
between June 1994 and February 2015. The change in the 
national standard deviation has been assessed over time, and 
differences due to the change between the two electron CoPs 
during this period has been quantified. The improvement in 
consistency for MV beams since the adoption of a CoP 
traceable to a primary standard of absorbed dose is assessed. 
 
Results: The mean NMI:Centre difference for radiation 
output calibration was less than 0.25% for all modalities. A 
total of 7 measurements were reported to be outside the +/-
2% tolerance.There was a statistically significant difference 
(p=0.008) in the mean result for the respective air kerma 
based electron CoP, +0.75% (n=14) with the absorbed dose 
based protocol giving +0.20% (n=84). 
The variation in MV results has decreased steadily over time 
(see Figure 1). The standard deviation has halved when 
comparing the first and last 20 results, being 0.85% (2000) 
and 0.35% (2015). This trend has also been noted within 
regional audit groups. A linear correlation was observed 
between the ‘NMI:Centre output ratio’ and the ‘NMI:Centre 
field chamber comparison ratio’. 
There has been no significant difference observed between 
regional audit and national audit for the measured 
NMI:Centre ratios, but some regions have had many more NMI 
audits than others, some having no beams audited for a 
particular modality, and others having more than 20. 
 
Conclusion: Data has been collated from 20 years of NMI 
reference dosimetry audits, and key trends and changes have 
been noted. The introduction of the 2003 absorbed dose-
based electron CoP has decreased the difference between 
NMI and centre measured outputs. The use of a single 
absorbed dose based MV CoP, introduced just prior to the 
start of these audits, has contributed to the improved 
consistency demonstrated in these results. This not only 
shows the impact of a rigorous traceability chain developed 
by close collaboration between NMI and end users but also 
demonstrates that the NMI audit programme is likely to be a 
contributing factor to this improvement in consistency in 
dosimetry nationally. 
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Purpose or Objective: In the DBCG HYPO trial a number of 
radiation therapy (RT) parameters were prospectively 
determined for each individual treatment plan. These 
parameters were reported to a database and analyzed to 
determine the plan quality in the trial. 
 
Material and Methods: Patients (pts) for breast-only RT after 
surgery for early node-negative breast cancer from 8 RT 
centre in 3 countries were included in the trial between May 
2009 and March 2014. They were randomized to either 40 
Gy/15 fx or 50 Gy/25 fx. A number of plan-quality 
parameters such as doses to CTV-breast and organs at risk 
were determined for each plan. The use of respiratory gating 
during treatment was reported. Definitions on compliance to 
protocol guidelines, as well as minor and major deviations 
(Table 1) were agreed upon before trial start. After closing 
the trial, the QA parameters were analyzed and scored. 
 
